Cargando…
Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
BACKGROUND: To compare the efficacy of conventional debulking surgery and cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with the peritoneal metastasis of epithelial ovarian cancer (EOCPC). METHODS: In patients with ovarian cancer who underwent surgery...
Autores principales: | Zhang, Jue, Li, Xin-Bao, Ma, Ru, Ji, Zhong-He, Bai, Wenpei, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798645/ https://www.ncbi.nlm.nih.gov/pubmed/35116671 http://dx.doi.org/10.21037/tcr-20-3233 |
Ejemplares similares
-
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients
por: Zhang, Jue, et al.
Publicado: (2021) -
Corrigendum to “Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients”
por: Zhang, Jue, et al.
Publicado: (2021) -
Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
por: Zhang, Jue, et al.
Publicado: (2020) -
Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan
por: Hsieh, Mao-Chih, et al.
Publicado: (2017) -
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Intraoperative Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer
por: Tentes, Antonios-Apostolos K., et al.
Publicado: (2012)